Skip to main content
. 2010 Sep 12;19(10):1581–1591. doi: 10.1007/s00520-010-0986-7

Table 1.

Descriptive statistics by research sample

Attrition patient sample, baseline characteristics (N in parentheses) Studied patient sample (N = 44) P value (mean difference between the attrition and studied patient samples)
N Mean SD 95% CI for mean Mean SD 95% CI for mean
Fatigue
 Baseline
 Fatigue score 118 0.53 1.46 0.27–0.80 0.30 1.17 −0.06–0.65 0.33
 Any fatigue 118 0.14 0.35 0.08–0.21 0.09 0.29 0.01–0.18 0.37
 Clinically significant fatigue 118 0.08 0.28 0.03–0.14 0.02 0.15 −0.02–0.07 0.07
 9 months and after
 Fatigue score 1.68 2.26 0.99–2.37
 Any fatigue 0.41 0.50 0.26–0.56
 Clinically significant fatigue 0.25 0.44 0.12–0.38
Demographics, baseline
 Age 45 and below 127 0.22 0.42 0.15–0.29 0.39 0.49 0.24–0.54 0.03
 Race/ethnicity
 White 127 0.75 0.43 0.68–0.83 0.86 0.35 0.76–0.97 0.14
 African American 127 0.20 0.40 0.13–0.27 0.09 0.29 0.01–0.18 0.06
 Other 127 0.05 0.21 0.01–0.08 0.05 0.21 −0.02–0.11 0.96
 Married 126 0.81 0.39 0.74–0.88 0.91 0.29 0.82–1.00 0.08
 Has any child 202 0.84 0.37 0.79–0.89 0.84 0.37 0.73–0.95 0.99
Biological variables, baseline
 Baseline
 BMI ≥ 25 121 0.52 0.50 0.43–0.61 0.45 0.50 0.30–0.61 0.46
 Reached menopause 127 0.63 0.48 0.55–0.72 0.52 0.51 0.37–0.68 0.21
 Tumor size 127 1.28 0.64 1.16–1.39 1.30 0.59 1.11–1.48 0.86
 Number of positive nodes 126 1.87 5.28 0.93–2.80 0.95 1.92 0.37–1.54 0.10
 ER positive 127 0.76 0.43 0.69–0.84 0.91 0.29 0.82–0.99 0.01
 Her2Neu positive 127 0.18 0.39 0.11–0.25 0.16 0.37 0.05–0.27 0.74
 Hemoglobin, actual value 169 13.08 1.62 12.84–13.33 13.11 1.73 12.58–13.64 0.93
 Hemoglobin > =11 169 0.93 0.25 0.90–0.97 0.93 0.25 0.85–1.01 0.94
 Glucose, actual value 162 101.54 36.66 95.85–107.23 99.34 22.40 92.53–106.15 0.71
 Glucose > =110 162 0.21 0.41 0.15–0.27 0.16 0.37 0.05–0.27 0.46
 White blood cell, actual value 169 7.00 2.55 6.61–7.39 6.48 1.75 5.95–7.01 0.21
 White blood cell abnormal 169 0.30 0.46 0.23–0.37 0.34 0.48 0.20–0.49 0.62
 Affected limb volume 116 1,299.76 396.93 1,226.76–1,372.76 1,207.93 233.67 1,136.89–1,278.97 0.07
Biological variables, 9 months and after
 BMI > =25 0.45 0.50 0.30–0.61
 Hemoglobin, actual value 12.68 1.13 12.33–13.02
 Hemoglobin > =11 0.91 0.29 0.82–1.00
 Glucose, actual value 99.91 37.48 88.52–111.31
 Glucose > =110 0.16 0.37 0.05–0.27
 White blood cell, actual value 5.70 1.62 5.21–6.19
 White blood cell abnormal 0.20 0.41 0.08–0.33
 Affected limb volume 1,253.93 250.39 1,177.81–1,330.06
Treatment variables
 Type of surgery
 Lumpectomy 0.39 0.49 0.24–0.54
 Modified mastectomy 0.52 0.51 0.37–0.68
 Simple mastectomy 0.09 0.29 0.01–0.18
 Had chemotherapy 0.52 0.51 0.37–0.68
 Had XRT 0.68 0.47 0.54–0.83
 Had hormonal therapy 0.86 0.34 0.76–0.97
Functioning variables, 12 months and after
 Vigorous activity
 Time vigorous activity, weekday 0.81 0.91 0.53–1.08
 Time vigorous activity, weekend 1.19 1.19 0.83–1.56
 Average time on vigorous activity (per day) 0.92 0.92 0.64–1.20
 Sleeping
 Time sleeping weekday 8.13 1.15 7.77–8.48
 Time sleeping weekend 8.53 1.04 8.22–8.85
 Average time sleeping (per day) 8.33 1.04 8.01–8.65
 Physical function
 Physical function subscale 86.93 13.78 82.74–91.12
 Physical function total composite 78.73 13.91 74.50–82.96
 Mental health
 Mental health score 63.09 13.47 58.99–67.19
 Mental health total composite 72.27 14.10 67.99–76.56
 Vitality 49.77 17.75 44.38–55.17
 Social function 89.30 18.13 83.78–94.81